Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...

BofA securities has upgraded Roche to a "buy," setting a target price of CHF 340, due to a positive outlook on the company's growth. Meanwhile, Deutsche Bank has downgraded the stock to "sell ...

FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an ...

Viking Therapeutics stock has jumped 10% on Wednesday, currently hovering above $60. Market Domination hosts Julie Hyman and Josh Lipton report on the analyst note, also noting Novo Nordisk's (NVO) ...

Vanguard International Stock Index-Vanguard European Stock Index 59.75k Apr 30, 2024 0.06% 19,840,617 Vanguard Intl Equity Index - Total World Stock Index Fd 68.53k Apr 30, 2024 0.06% 22,755,064 ...

Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...

Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer patients in the United States.

As of 2:24 pm GMT+9. Market open. Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the expansion of its digital pathology open environment with the integration of more than 20 advanced artificial ...

It had a large slug of assets in developed Europe, including longtime holdings Nestle, Air Liquide, Schneider, and Roche. Stock selection rather than sector bets drive sector and region ...

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.